))
Season 2 - Ep. 8: Atrial shunt devices in HF - Cardiovascular risk in master athletes
Manage episode 407315168 series 3559418
Conteúdo fornecido por European Society of Cardiology. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por European Society of Cardiology ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
Atrial shunt devices in heart failure
Cardiovascular risk in master athletes
Mythbusters: Monday mornings are dangerous
Host: Susanna Price
Guests: Carlos Aguiar, Sanjiv Shah, Sanjay Sharma
Want to watch that episode? Go to: https://esc365.escardio.org/event/1143
Disclaimer
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Sanjay Sharma have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.
Sanjiv Shah has declared to have potential conflicts of interest to report: global PI for the Corvia REDUCE LAP-HF I & II and RESPONDER-HF trials of an atrial shunt device for HFpEF. Consultant to Alleviant, Edwards, and Shifamed, each of which has developed devices for atrial shunting.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
40 episódios
Compartilhar
